175 years of know-how
Founded in 1847, Thuasne designs, develops and manufactures medical devices allowing everyone to become active players in their own health.
Over 6 generations of entrepreneurs, the French Group offers specific, adapted and innovative health solutions in the fields of orthopaedics, medical compression, home support and sport.
Today, Thuasne generates 250 million Euros in turnover, 50% of which comes from international sales, with 2,400 employees around the globe and presence in 85 countries, especially through its 15 subsidiaries in Europe, USA and Asia*.
“It was in 1847, in the North for France, that the company that would go on to become the Thuasne Group was created. For decades, thousands of employees have been working with us with a single objective in mind, health. It is this shared passion that still drives us today and will continue to do so for many years to come. ”
An agile company, today dedicated to health
FLEXIBLE AND COMPETITIVE INDUSTRIAL EXPERTISE
Since its creation, Thuasne has been developing and furthering its know-how, while constantly adapting its industrial model to manage the entire value chain.
Weaving, knitting, welding, carbon fibre, aluminium… today the Group has a highly comprehensive range of processes and materials that enable it to produce the most highly sophisticated medical devices. It also has the industrial capacity to mass-produce made-to-measure products.
In figures
14
industrial sites in Europe and the USA, including 5 in France
8 000
references
10 000
orders processed daily
15 million
kilometres of thread knitted
INNOVATION AT THE CENTRE OF THE STRATEGY
At Thuasne, innovation is not an idle word, it is part of the company’s historic culture, with patients’ health at the forefront.
This culture which drives the Group’s teams is all about varied and complementary skills, an effective corporate structure and financial means, with almost 5% of turnover being invested*.
In figures
4
R&D centres in Germany, USA, France and the United Kingdom
100
active patents
30 to 40
new medical devices each year
20
ongoing clinical studies
AN AMBITIOUS INTERNATIONAL GROWTH STRATEGY
Thuasne has built on its position as major stakeholder on the French market and has adopted a strategy to gradually win over other areas over thirty years, initially in Europe, then worldwide. With fifteen subsidiaries in Europe, USA and Asia, Thuasne is today one of the major stakeholders on the international medical device market.
BOLDNESS FOR THE FUTURE
Loyal to its values and its commitments, Thuasne’s longevity and growth is built on its greatest strengths that are its employees, innovation, internationalisation, digitalisation and industrial performance. The company’s future also relies on a practical CSR strategy, based on achievable and measurable objectives which will enable the Group to make tangible progress.
“The search for excellence motivates our teams to find increasingly suitable solutions. Becoming a leading global group known for its healthcare solutions is our ambition on a daily basis.”
ZMIROV COMMUNICATION
64 rue Jean-Jacques Rousseau
75001 Paris Chloé Jean-Baptiste
Tél. : 01 55 34 37 67
chloe.jean-baptiste@zmirov.com